Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2005
12/28/2005CN1233387C Chinese compound medicine for treating anhypnosis and its preparation method
12/28/2005CN1233384C Chinese medicine compound preparation for treating depression
12/28/2005CN1233375C Oral medicine for treating aphronesia
12/28/2005CN1233337C Medicine for treating Parkinson's disease and its preparing process
12/28/2005CN1233334C Oral liquid for detoxicating and dispelling wind
12/28/2005CN1233332C Medicine for treating vesanic disease by adopting head osmotic therapy
12/28/2005CN1233331C Medicine for treating epilepsy by adopting head osmotic therapy
12/28/2005CN1233316C Use of asafetida extract in production of medicine
12/28/2005CN1233279C Health-care beverage for relieving acute alcoholism
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979695 Compounds capable of activating cholinergic receptors
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979690 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979680 Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005US6979437 Drug delivering by inhaling or breathing to respiratory tract with a reduced drug dosage, comparing with traditional oral administration; dry powder drugs, emergency treatment
12/27/2005CA2327187C Transdermal therapeutic system containing pergolide
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121088A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
12/22/2005WO2005121087A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
12/22/2005WO2005121080A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005WO2005121078A2 Substituted cyclopentene compounds
12/22/2005WO2005121070A1 Levodopa prodrugs, and compositions and uses thereof
12/22/2005WO2005121069A1 Levodopa prodrugs, and compositions and uses thereof
12/22/2005WO2005120570A2 Therapeutic targeting of parc/ccl18 and its signaling in pulmonary fibrosis
12/22/2005WO2005120542A2 Methods of treating disease with random copolymers
12/22/2005WO2005120523A1 Methods and compositions for treating mood disorder
12/22/2005WO2005120519A1 Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors
12/22/2005WO2005120490A1 Capsule stable against mastication
12/22/2005WO2005120487A2 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders
12/22/2005WO2005120435A2 Method for preparing sustained release compositions and the use of said compositions for treating chronic diseases of central nervous system (cns)
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2004105789A8 Grf analog compositions and their use
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/22/2005US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
12/22/2005US20050282891 Parkinson's disease, depression, attention deficit disorder; schizophrenia, manic depression, cognitive impairment disorders, restless legs syndrome, periodic limb movement disorders, Huntington's disease, Tourette's syndrome, congestive heart failure, sustained release
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282880 Novel 1H-indazole compounds
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282869 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
12/22/2005US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282865 Neurotrophic factor production promoter
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282843 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282796 Tetracyclic azepinoindole compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282740 Methods and compositions for regulating protein-protein interactions
12/22/2005US20050282276 Cell fractions containing cells capable of differentiating into neural cells
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050279350 Methods and apparatus for relieving headaches, rhinitis and other common ailments
12/22/2005DE19814084B4 D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's disease and process for its preparation
12/22/2005DE10042412B4 Transceiver for bus subscriber of bus system of building system engineering, has two wires, where microcontroller is connected with receiver unit over connection on one hand, which is connected to two wires of bus system
12/22/2005CA2569891A1 Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors
12/22/2005CA2569843A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
12/22/2005CA2569842A1 New substituted piperidines as modulators of dopamine neurotransmission
12/22/2005CA2569746A1 Capsule stable against mastication
12/22/2005CA2569662A1 Heparin binding peptide
12/22/2005CA2569411A1 Methods and compositions for treating mood disorder
12/22/2005CA2568632A1 Levodopa prodrugs, and compositions and uses thereof
12/22/2005CA2567847A1 Novel tetracyclic tetrahydrofuran derivatives
12/22/2005CA2567513A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005CA2565703A1 Methods of treating disease with random copolymers
12/21/2005EP1607394A1 Water-soluble thalidomine derivatives
12/21/2005EP1607100A1 Remedy for spinal injury containing interleukin-6 antagonist
12/21/2005EP1607099A1 Use of hyperforin derivatives as an antidepressant agent
12/21/2005EP1607093A1 Improved delivery of multiple doses of medications
12/21/2005EP1606630A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
12/21/2005EP1606396A2 Methods of promoting the differentiation of stem cells
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1606292A2 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606281A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/21/2005EP1606278A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
12/21/2005EP1606277A1 Imidazol-4-yl-ethynyl-pyridine derivatives
12/21/2005EP1606269A1 Biaryl substituted triazoles as sodium channel blockers
12/21/2005EP1606247A1 Substituted aniline derivatives
12/21/2005EP1606244A2 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant
12/21/2005EP1606020A2 5ht2c receptor antagonists in the treatment of schizophrenia
12/21/2005EP1605964A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
12/21/2005EP1605950A2 Novel chemical entities and methods for their use in treatment of metabolic disorders
12/21/2005EP1605940A1 METHOD FOR TREATING MILD COGNITIVE IMPAIRMENT AND FOR PREVENTING OR DELAYING ALZHEIMER’S DISEASE
12/21/2005EP1605932A1 Intranasal formulation of rotigotine
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1419237A4 Animal model for fatty acid amide-related neurobehaviors
1 ... 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 ... 1833